(S)-(+)-2-benzyloxybutanol | 88376-72-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-(+)-2-benzyloxybutanol
• 英文别名: (2S)-2-(Benzyloxy)butan-1-ol；(2S)-2-phenylmethoxybutan-1-ol
• CAS: 88376-72-1
• 化学式: C₁₁H₁₆O₂
• 分子量: 180.247
• InChiKey: JRQIUTBHFLCSIT-NSHDSACASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S)-(+)-2-benzyloxybutanol 生成 (S)-1,2-丁二醇
  参考文献：
  名称：

  KATO YASUO; OHTA HIROMICHI; TSUCHIHASHI GEN-ICHI, TETRAHEDRON LETT., 28,(1987) N 12, 1303-1306

  摘要：

  DOI：
• 作为产物：
  描述：

  [(1R,2R,3S,4S)-3-[N-(benzenesulfonyl)-3,5-dimethylanilino]-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl] 2-phenylmethoxyacetate 在 六甲基磷酰三胺 、 lithium aluminium tetrahydride 、 lithium cyclohexylisopropylamide 作用下， 以 四氢呋喃 为溶剂， 生成 (S)-(+)-2-benzyloxybutanol
  参考文献：
  名称：

  Helmchen, Guenter; Wierzchowski, Reiner, Angewandte Chemie, 1984, vol. 96, # 1, p. 59 - 60

  摘要：

  DOI：

文献信息

• Convergent Approach to Pumiliotoxin Alkaloids. Asymmetric Total Synthesis of (+)-Pumiliotoxins A, B, and 225F
  作者：Sakae Aoyagi、Shintaro Hirashima、Kosuke Saito、Chihiro Kibayashi

  DOI：10.1021/jo0200466

  日期：2002.8.1

  (Z)-iodoalkylidene indolizidine 34, which served as a common key intermediate, was synthesized through highly stereoselective addition of the chiral silylallene 19 to (S)-acetylpyrrolidine followed by a palladium-catalyzed intramolecular carbonylation[bond]cyclization sequence. This synthetic process allowed the first total synthesis of (+)-pumiliotoxin 225F. The intermediate (Z)-iodoalkylidene indolizidine 34 obtained

  利用Pd（0）催化的均烯酸有机锌和乙烯基碘化物之间的交叉偶联反应，已经开发了一种通用的会聚方法来制备pumiliotoxin生物碱。通过将手性甲硅烷基亚烷基19高度立体选择性地加成到（S）-乙酰基吡咯烷中，然后钯催化的分子内羰基化键合环化序列，合成了用作常见关键中间体的（Z）-碘亚烷基吲哚并吡啶34。该合成过程允许（+）-pumiliotoxin 225F的第一个全合成。将获得的中间体（Z）-碘亚烷基吲哚并吡啶34转化为均烯丙基氯化锌衍生物，并使用Pd（PPh（3））（4）催化剂与（E）-乙烯基碘42进行均烯丙基-乙烯基交叉偶联，得到带有1，5-二烯侧链的交叉偶联产物47。
• AN ASYMMETRIC SYNTHESIS OF α-BENZYLOXY ALDEHYDES HAVING A CHIRAL TERTIARY CENTER—AN APPLICATION TO THE ASYMMETRIC SYNTHESIS OF<i>exo</i>-(+)-BREVICOMIN—
  作者：Masatoshi Asami、Teruaki Mukaiyama

  DOI：10.1246/cl.1983.93

  日期：1983.1.5

  α-Benzyloxy aldehydes having a chiral tertiary center at α-carbon atom are synthesized in high enantiomeric excess by successive treatment of 2-methoxycarbonyl-3-phenyl-1,3-diazabicyclo[3.3.0]octane with diisobutylaluminum hydride (DIBAL-H) and Grignard reagents. The asymmetric reaction is applied to the total synthesis of exo-(+)-brevicomin.

  通过用氢化二异丁基铝（DIBAL-H）和格氏试剂连续处理 2-甲氧基羰基-3-苯基-1,3-二氮杂双环[3.3.0]辛烷，合成出对映体过量的、在 α 碳原子上具有手性叔中心的 α-苄氧基醛。该不对称反应被用于外-(+)-brevicomin 的全合成。
• Mulzer, Johann; Angermann, Alfred; Muench, Winfried, Liebigs Annalen der Chemie, 1986, # 5, p. 825 - 838
  作者：Mulzer, Johann、Angermann, Alfred、Muench, Winfried

  DOI：——

  日期：——
• Enantioselective Synthesis of Chiral β-Aryloxy Alcohols by Asymmetric Hydrogenation of α-Aryloxy Aldehydes via Dynamic Kinetic Resolution
  作者：Zhang-Tao Zhou、Jian-Hua Xie、Qi-Lin Zhou

  DOI：10.1002/adsc.200800634

  日期：2009.2

  Abstractmagnified imageA catalytic enantioselective hydrogenation of racemic α‐aryloxy aldehydes via dynamic kinetic resolution has been developed by using (diamine)(spirodiphosphine)ruthenium(II) chloride [RuCl2(SDPs)(diamine)] catalysts. Employing this new reaction system a variety of optically active β‐aryloxy primary alcohols were synthesized in high yields and moderate to good enantioselectivities.
• On the conversion of structural analogues of (S)-2-hydroxypropylphosphonic acid to epoxides by the final enzyme of fosfomycin biosynthesis in S. fradiae
  作者：Anna Schweifer、Friedrich Hammerschmidt

  DOI：10.1016/j.bmcl.2007.12.012

  日期：2008.5

  2-Hydroxyethyl- and (S)-2-hydroxybutylphosphonic acid were prepared, starting in the latter case from (S)-2-aminobutyric acid. They were fed to cultures of Streptomyces fradiae producing fosfomycin. Only the latter (150 mu g/mL of medium) was converted to the ethyl analogue of fosfomycin, isolated as 2-amino-1-hydroxybutylphosphonic acid (3%)in admixture with 2-amino-1-hydroxypropylphosphonic acid (97%) derived from fosfomycin. (c) 2008 Elsevier Ltd. All rights reserved.